A retrospective cohort study of 587 patients with metastatic cancer linked influenza vaccination during checkpoint inhibitor therapy to longer progression-free survival, without significantly higher IRAE...
An English cohort emulating a randomized trial linked influenza vaccination to lower influenza hospitalization risk in adults ≥40 with COPD, although residual confounding remained.
A multisite surveillance study published in Pediatrics assessed trends and determinants of influenza antiviral use in hospitalized children across the United States before and during the late COVID-19...
August 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a...
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
New influenza and RSV research offers clinically relevant insights into vaccine performance and outbreak prevention. This roundup examines an investigational mRNA flu vaccine, rapid oseltamivir use in...